BLACKLEDGER Selling Watch: RXRX, TSM, BA
BLACKLEDGER's latest selling watch update tracks RXRX, TSM, BA, KULR, MVST, NFLX from the active public watchlist. This post is built from public-safe status data, in-house public signal labels, and outside public source context. It is designed to help readers understand what is happening around each asset without exposing private research methods.
Selling Watch Data
The dedicated feed category for this update is Selling. The latest public scan timestamp is 2026-07-14T08:00:51.271464+00:00.
- RXRX (stock): Bear public bias, Extended, public score 8.0/10, status: Paper trading research.
- TSM (stock): Bear public bias, Extended, public score 8.0/10, status: Paper trading research.
- BA (stock): Bear public bias, Extended, public score 8.0/10, status: Paper trading research.
- KULR (stock): Bear public bias, Extended, public score 8.0/10, status: Paper trading research.
- MVST (stock): Bear public bias, Extended, public score 8.0/10, status: Paper trading research.
- NFLX (stock): Bear public bias, A-List, public score 7.5/10, status: Paper trading research.
- EVGO (stock): Bear public bias, A-List, public score 6.5/10, status: Paper trading research.
- SMCI (stock): Bear public bias, A-List, public score 6.5/10, status: Paper trading research.
Educational Context: How To Use This Page
This page is not a trade instruction. It is an educational research brief. Readers can use it to understand company or project background, public market context, public status labels, and relevant outside-source headlines before doing their own due diligence.
RXRX Public Research Bio
Deep bio flag: This asset reached the 9+ public rating threshold, so BLACKLEDGER includes a fuller company/project profile, outside-source context, and public education notes.
Name: Recu[redacted]on Pharmaceuticals, Inc.. Market class: stock. Public bias: Bear. Public tier: Extended.
Recu[redacted]on Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States and the United Kingdom. The company develops REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-617, which is in Phase 1/2 clinical trial to treat advanced solid tumors; REC-1245, which is in Phase 1/2 clinical trial to treat biomarker-enriched solid tumors and lymphoma; REC-3565 that is in Phase 1/2 for the treatment of relapsed or refractory B-cell malignancies; and REC-4539, a reve[redacted]ble, CNS penetrant, orally bioavailable, and potential best-in-class inhibitor of LSD1 for the treatment of solid tumors and h[redacted]tology oncology. Its preclinical stage product includes REC-7735 for the treatment of
- Latest public price/reference: $3.295
- Public market capitalization: $1.75B
- Recent public volume/reference: 24.39M
- One-month public movement: -10.7%
- Sector/category: Healthcare
Why RXRX Is In This Public Update
- BLACKLEDGER public score is in the 7.0-8.9 confirmation band (the most reliable tier), so this asset receives a deep public bio and outside-source review.
- Current public status: Paper trading research. Public confidence label: High Confidence.
- Current public directional label: bear. This is research context only, not an execution instruction.
Outside Public Headlines / Source Notes
- 2 Beaten-Down Stocks That Still Aren't Worth Buying — Motley Fool
- Is Recu[redacted]on Pharmaceuticals (RXRX) The Best Penny Stocks According to Billioanires? — Insider Monkey
- Here's Why Recu[redacted]on Pharmaceuticals (RXRX) Fell More Than Broader Market — Zacks
- Recu[redacted]on Pharmaceuticals (RXRX) Is Up 8.0% After Russell Index Additions Expand Its Investor Base – Has The Bull Case Changed? — Simply Wall St.
TSM Public Research Bio
Deep bio flag: This asset reached the 9+ public rating threshold, so BLACKLEDGER includes a fuller company/project profile, outside-source context, and public education notes.
Name: Taiwan Semiconductor Manufacturing Company Limited. Market class: stock. Public bias: Bear. Public tier: Extended.
Taiwan Semiconductor Manufacturing Company Limited, together with its subsidiaries, manufactures, packages, tests, and sells integrated circuits and other semiconductor devices in Taiwan, China, Europe, the Middle East, Africa, Japan, the United States, and internationally. It provides various wafer fabrication processes, such as processes to manufacture complementary metal- oxide-semiconductor (CMOS) logic, mixed-signal, radio frequency, embedded memory, bipolar CMOS mixed-signal, and others. The company also involved in providing customer and engineering support services; manufacturing of masks; investment in technology start-up companies; research, designing, developing, manufacturing, packaging, testing, and sale of color filters; and investment activities. Its products are used in high performance computing, [redacted]rtphones, Internet of things, automotive, and digital consumer electronics. Taiwan Semiconductor Manufacturing Comp
- Latest public price/reference: $421.7
- Public market capitalization: $2186.51B
- Recent public volume/reference: 14.19M
- One-month public movement: -3.99%
- Sector/category: Technology
Why TSM Is In This Public Update
- BLACKLEDGER public score is in the 7.0-8.9 confirmation band (the most reliable tier), so this asset receives a deep public bio and outside-source review.
- Current public status: Paper trading research. Public confidence label: High Confidence.
- Current public directional label: bear. This is research context only, not an execution instruction.
Outside Public Headlines / Source Notes
- Chip toolmaker ASML expected to shine light on capacity and China challenges — Reuters
- TSMC seen riding AI boom to fifth straight quarter of record profit — Reuters
- The whole chip trade is waiting on one report — TheStreet
- Analyst Dan Ives Calls Memory Chips the “Golden Child” of the AI Revolution with “15-to-1” D[redacted]nd-to-Supply Imbalance — 24/7 Wall St.
BA Public Research Bio
Deep bio flag: This asset reached the 9+ public rating threshold, so BLACKLEDGER includes a fuller company/project profile, outside-source context, and public education notes.
Name: The Boeing Company. Market class: stock. Public bias: Bear. Public tier: Extended.
The Boeing Company, together with its subsidiaries, designs, develops, manufactures, sells, services, and supports commercial jetliners, military aircraft, satellites, missile defense, human space flight and launch systems, and services worldwide. The company operates through three segments: Commercial Airplanes; Defense, Space & Security; and Global Services. The Commercial Airplanes segment develops, produces, and markets commercial jet aircraft for passenger and cargo requirements. The Defense, Space & Security segment engages in the research, development, production, and modification of manned and unmanned military aircraft and weapons systems; strategic defense and intelligence systems, which include strategic missile and defense systems, command, control, communications, computers, intelligence, surveillance and reconnaissance, cyber and information solutions, and intelligence systems; and satellite systems, such as government and
- Latest public price/reference: $215.5
- Public market capitalization: $169.89B
- Recent public volume/reference: 4.66M
- One-month public movement: -0.77%
- Sector/category: Industrials
Why BA Is In This Public Update
- BLACKLEDGER public score is in the 7.0-8.9 confirmation band (the most reliable tier), so this asset receives a deep public bio and outside-source review.
- Current public status: Paper trading research. Public confidence label: High Confidence.
- Current public directional label: bear. This is research context only, not an execution instruction.
Outside Public Headlines / Source Notes
- The Iran War Hasn’t Helped Defense Stocks. Maybe Earnings Can. — Barrons.com
- Hexcel vs. Textron: Which Key Industrial Supplier Stock Is a Better Buy in 2026? — Motley Fool
- Boeing Stock And The Number Behind The Worry — Trefis
- Missed GE’s Aerospace Rally? XLI Holders Made More Money — 24/7 Wall St.
KULR Public Research Bio
Deep bio flag: This asset reached the 9+ public rating threshold, so BLACKLEDGER includes a fuller company/project profile, outside-source context, and public education notes.
Name: KULR Technology Group, Inc.. Market class: stock. Public bias: Bear. Public tier: Extended.
KULR Technology Group, Inc., through its subsidiary, KULR Technology Corporation, designs and builds advanced battery systems for autonomous platforms, digital infrastructure, and e-mobility and space. It provides battery production, internal short circuit battery cells and devices, patented thermal runaway shield technology (TRS), phase change material (PCM) heatsinks, and KULR SafeCases, and exoskeleton devices. The company also offers space batteries; air batteries; custom battery design; battery solutions, including trigger cells and ISC-D and SafeX Safe storage solutions; thermal solutions, including fiber thermal interface and cathodes; and testing solutions that include cell screening and cycling, module cycling, thermal desktop and SINDA/FLUINT, and abuse testing and calorimetry. Additionally, the company provides KULR VIBE, a software-driven precision balancing and vibration reduction solution designed for rotary systems an
- Latest public price/reference: $2.96
- Public market capitalization: $136.92M
- Recent public volume/reference: 1.95M
- One-month public movement: -20.24%
- Sector/category: Technology
Why KULR Is In This Public Update
- BLACKLEDGER public score is in the 7.0-8.9 confirmation band (the most reliable tier), so this asset receives a deep public bio and outside-source review.
- Current public status: Paper trading research. Public confidence label: High Confidence.
- Current public directional label: bear. This is research context only, not an execution instruction.
Outside Public Headlines / Source Notes
- Can KULR Benefit From Key Expertise in the Expanding Drone Market? — Zacks
- KULR Technology Group (KULR) Is Down 20.3% After Securing Defense Drone Battery Prototype Deal – Has The Bull Case Changed? — Simply Wall St.
- Why KULR Technology Group (KULR) Is Up 28.1% After Winning Argo Space Battery Contract — Simply Wall St.
- A Look At KULR Technology Group’s (KULR) Valuation After Mixed Q1 Results And Growth Expansion Plans — Simply Wall St.
MVST Public Research Bio
Deep bio flag: This asset reached the 9+ public rating threshold, so BLACKLEDGER includes a fuller company/project profile, outside-source context, and public education notes.
Name: Microvast Holdings, Inc.. Market class: stock. Public bias: Bear. Public tier: Extended.
Microvast Holdings, Inc. engages in the design, development, and manufacturing of battery components and systems primarily for electric commercial vehicles and energy storage systems. The company offers a range of cell chemistries, such as lithium titanate oxide, lithium iron phosphate, electrolyte formulation, full concentration gradient cathode, polyaramid separator, and nickel manganese cobalt. It also designs, develops, and manufactures components of lithium-ion batteries, such as cathode, anode, electrolytes, and separator. The company's commercial vehicle markets cover buses, trains, mining trucks, marine and port vehicles, and automated guided and specialty vehicles, as well as light, medium, and heavy-duty trucks. It operates in China, India, rest of the Asia Pacific, Italy, France, rest of Europe, and the United States. Microvast Holdings, Inc. was founded in 2006 and is headquartered in Stafford, Texas.
- Latest public price/reference: $0.9832
- Public market capitalization: $325.03M
- Recent public volume/reference: 12.96M
- One-month public movement: -11.42%
- Sector/category: Consumer Cyclical
Why MVST Is In This Public Update
- BLACKLEDGER public score is in the 7.0-8.9 confirmation band (the most reliable tier), so this asset receives a deep public bio and outside-source review.
- Current public status: Paper trading research. Public confidence label: High Confidence.
- Current public directional label: bear. This is research context only, not an execution instruction.
Outside Public Headlines / Source Notes
- Should You Buy Microvast Holdings (MVST) After a Sharp Decline? — Insider Monkey
- A Look At Microvast Holdings (MVST) Valuation After Governance Investigation And Executive Departure — Simply Wall St.
- 3 Growth Companies With High Insider Ownership And Up To 20% Revenue Growth — Simply Wall St.
- A Look At Microvast Holdings (MVST) Valuation After Weaker Q1 2026 Results — Simply Wall St.
NFLX Public Research Bio
Deep bio flag: This asset reached the 9+ public rating threshold, so BLACKLEDGER includes a fuller company/project profile, outside-source context, and public education notes.
Name: Netflix, Inc.. Market class: stock. Public bias: Bear. Public tier: A-List.
Netflix, Inc. provides entertainment services worldwide. The company offers television (TV) series, documentaries, feature films, games, and live programming across various genres and languages. It also provides members the ability to receive streaming content through a host of internet-connected devices, including TVs, digital video players, TV set-top boxes, and mobile devices. Netflix, Inc. was incorporated in 1997 and is headquartered in Los Gatos, California.
- Latest public price/reference: $73.86
- Public market capitalization: $310.88B
- Recent public volume/reference: 34.71M
- One-month public movement: -2.38%
- Sector/category: Communication Services
Why NFLX Is In This Public Update
- BLACKLEDGER public score is in the 7.0-8.9 confirmation band (the most reliable tier), so this asset receives a deep public bio and outside-source review.
- Current public status: Paper trading research. Public confidence label: Moderate Confidence.
- Current public directional label: bear. This is research context only, not an execution instruction.
Outside Public Headlines / Source Notes
- Netflix may be sitting on another tough quarter — Yahoo Finance
- How Netflix is fighting back against its 'biggest enemy' — Yahoo Finance Video
- Netflix (NFLX) Secures Exclusive MLB Home Run Derby Streaming Rights — Simply Wall St.
- S&P 500, Nasdaq, Dow End Lower As US-Iran War Fear Remerges — PSKY, META, GOOGL, INTC, NFLX In Focus — Stocktwits
What The Public Data Shows
The public feed highlights ticker status, market class, directional bias, score, tier, confidence, company or project profile, public market references, and outside-source headlines. These fields support a deeper view of BLACKLEDGER's public research feed while keeping private methods undisclosed.
Why This Category Matters
The Selling section gives readers a focused path through the market: buying watch content for constructive candidates, selling watch content for defensive movement, investing content for higher-quality public watch names, and market trend notes for broader context.
Research-Only Notice
BLACKLEDGER content is market research only. There is no live execution signal, no recommendation to buy or sell, and no financial advice. Readers should perform their own due diligence and consult licensed professionals before making financial decisions.
Research-only. No execution signal. Not financial advice.